{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:15:48Z","timestamp":1793578548321,"version":"4.5.0"},"reference-count":108,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Cardiac remodeling occurs frequently in chronic kidney disease patients and affects quality of life and survival. Current treatment options are highly inadequate. As kidney function declines, numerous metabolic pathways are disturbed. Kidney and heart functions are highly connected by organ crosstalk. Among others, altered volume and pressure status, ischemia, accelerated atherosclerosis and arteriosclerosis, disturbed mineral metabolism, renal anemia, activation of the renin-angiotensin system, uremic toxins, oxidative stress and upregulation of cytokines stress the sensitive interplay between different cardiac cell types. The fatal consequences are left-ventricular hypertrophy, fibrosis and capillary rarefaction, which lead to systolic and\/or diastolic left-ventricular failure. Furthermore, fibrosis triggers electric instability and sudden cardiac death. This review focuses on established and potential pathophysiological cardiorenal crosstalk mechanisms that drive uremia-induced senescence and disease progression, including potential known targets and animal models that might help us to better understand the disease and to identify novel therapeutics.<\/jats:p>","DOI":"10.3390\/toxins12030161","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T07:33:46Z","timestamp":1583480026000},"page":"161","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Cardiac Remodeling in Chronic Kidney Disease"],"prefix":"10.3390","volume":"12","author":[{"given":"Nadine","family":"Kaesler","sequence":"first","affiliation":[{"name":"Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Babler","sequence":"additional","affiliation":[{"name":"Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[{"name":"Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Kramann","sequence":"additional","affiliation":[{"name":"Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, 52074 Aachen, Germany"},{"name":"Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000489897","article-title":"On behalf of the GBD Genitourinary Diseases Expert Group Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study","volume":"139","author":"Bikbov","year":"2018","journal-title":"Nephron"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Richard Hobbs, F.D. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrneph.2010.191","article-title":"Sudden cardiac death in chronic kidney disease: Epidemiology and prevention","volume":"7","author":"Shamseddin","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCRESAHA.116.308139","article-title":"Recounting Cardiac Cellular Composition","volume":"118","author":"Zhou","year":"2016","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting Cardiac Cellular Composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcvm.2018.00167","article-title":"Single Cell Gene Expression to Understand the Dynamic Architecture of the Heart","volume":"5","author":"Massaia","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yjmcc.2019.11.152","article-title":"Cellular cross-talks in the diseased and aging heart","volume":"138","author":"Wagner","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41556-019-0446-7","article-title":"Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function","volume":"22","author":"Wang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fcvm.2018.00143","article-title":"Heterocellularity and Cellular Cross-Talk in the Cardiovascular System","volume":"5","author":"Perbellini","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fcvm.2018.00101","article-title":"Cardiomyocyte-Endothelial Cell Interactions in Cardiac Remodeling and Regeneration","volume":"5","author":"Talman","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1681\/ASN.2013070734","article-title":"Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD","volume":"25","author":"Kramann","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.17305\/bjbms.2004.3458","article-title":"Left ventricular hypertrophy and risk factors for its development in uraemic patients","volume":"4","year":"2004","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s004670000303","article-title":"Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors","volume":"14","author":"Mitsnefes","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1046\/j.1523-1755.1998.06818.x","article-title":"Left ventricular hypertrophy in renal failure","volume":"68","author":"Amann","year":"1998","journal-title":"Kidney Int. Suppl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2019.02.013","article-title":"Reduced Estimated GFR and Cardiac Remodeling: A Population-Based Autopsy Study","volume":"74","author":"Izumaru","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"a004242","DOI":"10.1101\/cshperspect.a004242","article-title":"Calcium signaling in cardiac myocytes","volume":"3","author":"Fearnley","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2019.04.042","article-title":"What is the role of peptide fragments of collagen I and IV in health and disease?","volume":"228","author":"Kisling","year":"2019","journal-title":"Life Sci."},{"key":"ref_20","first-page":"60","article-title":"Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease","volume":"90","author":"Rudenko","year":"2018","journal-title":"Ter. Arkh."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_1.29","article-title":"Left ventricular alterations and end-stage renal disease","volume":"17","author":"London","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_22","first-page":"225","article-title":"The extracellular matrix in human myocardium: Part I: Collagens I, III, IV, and VI","volume":"2","author":"Speiser","year":"1991","journal-title":"Cardioscience"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","article-title":"Cardiac interstitium in health and disease: The fibrillar collagen network","volume":"13","author":"Weber","year":"1989","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100389","DOI":"10.1016\/j.ijcha.2019.100389","article-title":"Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney disease","volume":"24","author":"Chen","year":"2019","journal-title":"IJC Heart Vasc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1291\/hypres.27.47","article-title":"Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients","volume":"27","author":"Nitta","year":"2004","journal-title":"Hypertens. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3109\/0886022X.2015.1061669","article-title":"Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1\u20133","volume":"37","author":"Pluta","year":"2015","journal-title":"Ren. Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"938651","DOI":"10.4061\/2011\/938651","article-title":"Cardiorenal Syndrome Type 4\u2014Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management","volume":"2011","author":"Pateinakis","year":"2011","journal-title":"Int. J. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature25739","article-title":"A molecular atlas of cell types and zonation in the brain vasculature","volume":"554","author":"Vanlandewijck","year":"2018","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/ATVBAHA.119.312399","article-title":"Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing","volume":"39","author":"Gu","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.stem.2016.08.001","article-title":"Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease","volume":"19","author":"Kramann","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1523-1755.2000.00936.x","article-title":"Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease","volume":"57","author":"Pannier","year":"2000","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1038\/s41598-018-23663-1","article-title":"Chronic kidney disease induces a systemic microangiopathy, tissue hypoxia and dysfunctional angiogenesis","volume":"8","author":"Prommer","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: A marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9036450","DOI":"10.1155\/2017\/9036450","article-title":"Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?","volume":"2017","author":"Duni","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fphys.2018.01648","article-title":"Mechanisms and Modulation of Oxidative\/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia","volume":"9","author":"Dux","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"F1499","DOI":"10.1152\/ajprenal.00058.2014","article-title":"NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease","volume":"306","author":"DuPont","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000046941","article-title":"Manifestations of oxidant stress in uremia","volume":"19","author":"Himmelfarb","year":"2001","journal-title":"Blood Purif."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"H475","DOI":"10.1152\/ajpheart.00628.2016","article-title":"Advanced oxidation protein products aggravate cardiac remodeling via cardiomyocyte apoptosis in chronic kidney disease","volume":"314","author":"Feng","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gupta, J., Dominic, E.A., Fink, J.C., Ojo, A.O., Barrows, I.R., Reilly, M.P., Townsend, R.R., Joffe, M.M., Rosas, S.E., and Wolman, M. (2015). Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124772"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1038\/s41598-019-46805-5","article-title":"Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease","volume":"9","author":"Freise","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5414\/CNP86S127","article-title":"Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients","volume":"86","author":"Hassan","year":"2016","journal-title":"Clin. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1347432","DOI":"10.1155\/2018\/1347432","article-title":"Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients","volume":"2018","author":"Dozio","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9845175","DOI":"10.1155\/2017\/9845175","article-title":"Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation","volume":"2017","author":"Dozio","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Kirchhoff","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"B\u00f6ckmann, I., Lischka, J., Richter, B., Deppe, J., Rahn, A., Fischer, D.-C., Heineke, J., Haffner, D., and Leifheit-Nestler, M. (2019). FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184634"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.RES.81.5.679","article-title":"Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy","volume":"81","author":"Corda","year":"1997","journal-title":"Circ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1113\/expphysiol.1998.sp004140","article-title":"Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats","volume":"83","author":"Scheinowitz","year":"1998","journal-title":"Exp. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yjmcc.2019.09.004","article-title":"The axis of local cardiac endogenous Klotho-TGF-\u03b21-Wnt signaling mediates cardiac fibrosis in human","volume":"136","author":"Liu","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000454959","article-title":"Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease","volume":"45","author":"Xue","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bone.2012.02.634","article-title":"Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis","volume":"50","author":"Nakano","year":"2012","journal-title":"Bone"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2013.09.002","article-title":"Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults","volume":"231","author":"Jovanovich","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Flasbart","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2215\/CJN.02110217","article-title":"FGF23 and Left Ventricular Hypertrophy in Children with CKD","volume":"13","author":"Mitsnefes","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfu190","article-title":"Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD","volume":"29","author":"Reuter","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fendo.2018.00278","article-title":"Paracrine Effects of FGF23 on the Heart","volume":"9","author":"Haffner","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1038\/s41598-018-32065-2","article-title":"Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms","volume":"8","author":"Robles","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Rodelo-Haad, C., Santamaria, R., Mu\u00f1oz-Casta\u00f1eda, J.R., Pend\u00f3n-Ruiz de Mier, M.V., Martin-Malo, A., and Rodriguez, M. (2019). FGF23, Biomarker or Target?. Toxins, 11.","DOI":"10.3390\/toxins11030175"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zou, D., Wu, W., He, Y., Ma, S., and Gao, J. (2018). The role of klotho in chronic kidney disease. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1094-z"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00467-017-3766-5","article-title":"The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease\u2014A prospective cohort study","volume":"33","author":"Olauson","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/s41598-017-02068-6","article-title":"FGF23\/FGFR4-mediated left ventricular hypertrophy is reversible","volume":"7","author":"Grabner","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1253\/circj.CJ-19-0872","article-title":"Uremic Toxin-Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome","volume":"84","author":"Taguchi","year":"2019","journal-title":"Circ. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1681\/ASN.2016111184","article-title":"Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia","volume":"28","author":"Yokoro","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","article-title":"Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure","volume":"21","author":"Tang","year":"2015","journal-title":"J. Card. Fail."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lekawanvijit, S. (2018). Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome. Toxins, 10.","DOI":"10.3390\/toxins10090352"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"For the European Uremic Toxin Work Group (EUTox), Vanholder, R., De Smet, R., Glorieux, G., Argil\u00e9s, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., and De Deyn, P.P. (2003). Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int., 63, 1934\u20131943.","DOI":"10.1046\/j.1523-1755.2003.00924.x"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/s41598-017-03130-z","article-title":"Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.yjmcc.2015.06.010","article-title":"CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia","volume":"85","author":"Lin","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gft268","article-title":"Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis","volume":"28","author":"Panizo","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Gluba-Brz\u00f3zka, A., Franczyk, B., Cia\u0142kowska-Rysz, A., Olszewski, R., and Rysz, J. (2018). Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients. Nutrients, 10.","DOI":"10.3390\/nu10060709"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2010.04.068","article-title":"Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia","volume":"56","author":"Ogino","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000353106","article-title":"Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5\/6 nephrectomized rats independently of blood pressure and kidney function","volume":"38","author":"Gut","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_81","first-page":"3","article-title":"Molecular insights into uremic cardiomyopathy: Cardiotonic steroids and Na\/K ATPase signaling","volume":"52","author":"Kennedy","year":"2006","journal-title":"Cell. Mol. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"34592","DOI":"10.1038\/srep34592","article-title":"Attenuation of Na\/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1152\/physiolgenomics.00116.2015","article-title":"Na\/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts","volume":"48","author":"Drummond","year":"2016","journal-title":"Physiol. Genom."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.kint.2017.05.014","article-title":"MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4","volume":"93","author":"Chuppa","year":"2018","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.114.303508","article-title":"S100\/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner","volume":"34","author":"Yan","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_86","first-page":"e279","article-title":"Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: A new link between S100\/RAGE and FGF23","volume":"1","author":"Yan","year":"2014","journal-title":"Inflamm. Cell Signal."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cardfail.2006.11.005","article-title":"Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure","volume":"13","author":"Li","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e12732","DOI":"10.14814\/phy2.12732","article-title":"Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD)","volume":"4","author":"Winterberg","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wang, X., Chaudhry, M.A., Nie, Y., Xie, Z., Shapiro, J.I., and Liu, J. (2017). A Mouse 5\/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy. J. Vis. Exp., e55825.","DOI":"10.3791\/55825-v"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/ndt\/gfp708","article-title":"Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB\/c without improving cardiac function","volume":"25","author":"Baumann","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"F450","DOI":"10.1152\/ajprenal.00472.2007","article-title":"Partial nephrectomy as a model for uremic cardiomyopathy in the mouse","volume":"294","author":"Kennedy","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"16087","DOI":"10.1038\/s41598-018-34216-x","article-title":"Pathological cardiac remodeling occurs early in CKD mice from unilateral urinary obstruction, and is attenuated by Enalapril","volume":"8","author":"Ham","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41374-018-0063-2","article-title":"Cisplatin nephrotoxicity as a model of chronic kidney disease","volume":"98","author":"Shi","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ndt\/gfx332","article-title":"Genetic background influences cardiac phenotype in murine chronic kidney disease","volume":"33","author":"Neuburg","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.05.024","article-title":"\u03b21-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy","volume":"73","author":"Rizzi","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/omi.2004.8.334","article-title":"Computational Searches for Missing Orthologs: The Case of S100A12 in Mice","volume":"8","author":"Fuellen","year":"2004","journal-title":"OMICS A J. Integr. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kieswich, J.E., Chen, J., Alliouachene, S., Caton, P.W., McCafferty, K., Thiemermann, C., and Yaqoob, M.M. (2018). A novel model of reno-cardiac syndrome in the C57BL\/ 6 mouse strain. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1155-3"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ekir.2018.10.004","article-title":"Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study","volume":"4","author":"Schneider","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"J-DAVID Investigators, Shoji, T., Inaba, M., Fukagawa, M., Ando, R., Emoto, M., Fujii, H., Fujimori, A., Fukui, M., and Hase, H. (2018). Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial. JAMA, 320, 2325\u20132334.","DOI":"10.1001\/jama.2018.17749"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1159\/000495540","article-title":"Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease","volume":"51","author":"Vera","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e004106","DOI":"10.1161\/JAHA.116.004106","article-title":"Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling","volume":"5","author":"Haller","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zapolski, T., Furmaga, J., Wysoki\u0144ski, A.P., Wysocka, A., Rudzki, S., and Jaroszy\u0144ski, A. (2019). The atrial uremic cardiomyopathy regression in patients after kidney transplantation\u2014The prospective echocardiographic study. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1333-y"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/ndt\/gfx029","article-title":"Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease","volume":"32","author":"Nazzal","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","article-title":"Recombinant \u03b1-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy","volume":"91","author":"Hu","year":"2017","journal-title":"Kidney Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.kisu.2017.09.002","article-title":"New options for the anemia of chronic kidney disease","volume":"7","author":"Coyne","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lfs.2016.02.019","article-title":"Increased rho kinase activity in mononuclear cells of dialysis and stage 3\u20134 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications","volume":"148","author":"Vertolli","year":"2016","journal-title":"Life Sci."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/3\/161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:04:18Z","timestamp":1760173458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/3\/161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":108,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["toxins12030161"],"URL":"https:\/\/doi.org\/10.3390\/toxins12030161","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]}}}